ERBB2 and breast cancer: Currently ongoing phase I clinical trials with HER2-CAR-T in patients with advanced HER2 BC include NCT369630 (including patients with CNS metastasis), NTC04511871 (using autologous T cells), and NCT04650451 (using the dual switch CAR-T BPX-603) [100].